Advertisement
Research Article| Volume 11, ISSUE 4, P361-372, August 1983

Role of renin release in the hemodynamic, renal and dipsogenic actions of the prostacyclin analogue CG 4203 in conscious rats

DOI:https://doi.org/10.1016/0262-1746(83)90088-4
Role of renin release in the hemodynamic, renal and dipsogenic actions of the prostacyclin analogue CG 4203 in conscious rats
Next ArticleAntipsoriatic drugs as inhibitors of soybean lipoxygenase. A possible mode of action
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The influence of CG 4203, a chemically and metabolically stable prostacyclin analogue, on plasma renin activity, arterial blood pressure, renal function and water intake was investigated in conscious rats. CG 4203 infused intravenously starting at 1 μg·kg−1·min−1 induced both a fall in blood pressure and an increase of plasma renin activity. The angiotensin II antagonist saralasine infused simultaneously intensified the hypotensive effect of CG 4203 (1.0 μg·kg−1·min−1. Within a similar dose range CG 4203 dose-dependently inhibited diuresis and saluresis and reduced the urinary sodium/potassium ratio. These effects were partially reversed by adrenalectomy and completely abolished by pretreatment with the angiotensin I converting enzyme inhibitor captopril. Similarly, CG 4203 (0.21 – 4.64 μg·kg−1·min−1 ) dose-dependently caused increased water intake which was prevented by previous nephrectomy. In conclusion, it is demonstrated that CG 4203 like prostacyclin itself already at hypotensive threshold dosages stimulates a functionally relevant renin release. The activation of the renin-angiotensin-aldosterone system attenuates the intrinsic hypotensive effects of CG 4203. The antidiuretic and dipsogenic efficacy of CG 4203 can also be attributed to renin-dependent angiotensin II formation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Schölkens B.A.
        Plasmarenin activity and vasodepressor action of prostacyclins with modified -side chain in anaesthetized rats.
        Prostaglandins and Medicine. 1980; 4: 357
        • Franco-Saenz R.
        • Suzuki S.
        • Tan S.Y.
        Prostaglandins and renin production: a review.
        Prostaglandins. 1980; 20: 1131
        • Seipp U.
        • Michel G.
        • Loschen G.
        • Kim S.-M.A.
        • Vollenberg W.
        • Frankus E.
        • Flohé L.
        Structure-activity relationship of PGI2 analogs.
        in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
        • Michel G.
        • Wilsmann K.
        CG 4203 (New stable prostacyclin analogue): effect on bleeding time and blood coagulation.
        in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
        • Michel G.
        • Friderichs E.
        • Müller B.
        • Wilsmann K.
        • Seipp U.
        • Flohé L.
        CG 4203 (New stable prostacyclin analogue): actions on platelets and blood pressure.
        in: 1st Intern. Austrian Prostaglan din Meeting, Bad Ischl1982
        • Müller B.
        • Wilsmann K.
        CG 4203 (New stable prostacyclin analogue): cardiovascular profile in anaesthetized rabbits.
        in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
        • Haber E.
        • Koerner T.
        • Page L.B.
        • Kliman B.
        • Purnode A.
        Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.
        J. Clin. Endocrinol. Metab. 1969; 29: 1349
        • Weeks J.R.
        • Compton L.D.
        The cardiovascular pharmacology of prostacyclin in the rat.
        Prostaglandins. 1979; 17: 501
        • Hall J.E.
        • Guyton A.C.
        • Salgado H.C.
        • McCaare
        • Malfe J.W.
        Renal hemodynamics in acute and chronic angiotensin II hypertension.
        Am. J. Physiol. 1978; 236: F174
        • Lohmeier T.E.
        • Cowley A.W.
        Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog.
        Circ. Res. 1979; 44: 154
        • Hashimoto T.
        Effects of prostaglandin E2, I2 and F2α on systemic and renal hemodynamics, renal function and renin secretion in anesthetized dogs.
        Japan. J. Pharmacol. 1980; 30: 173
        • Fitzsimons J.T.
        Thirst.
        Physiol. Rev. 1972; 52: 468
        • Fitzsimons J.T.
        The renin angiotensin system and drinking behaviour.
        Progr. Brain Res. 1975; 42: 215
        • Keeton T.K.
        • Campbell W.B.
        The pharmacologic alteration of renin release.
        Pharmacol. Rev. 1981; 31: 81
        • Whorton A.R.
        • Misono K.
        • Hollifield J.
        • Frölich J.C.
        Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2.
        Prostaglandins. 1977; 14: 1095

      Article info

      Identification

      DOI: https://doi.org/10.1016/0262-1746(83)90088-4

      Copyright

      © 1983 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX